Figure 2.
Figure 2. T lymphocytes redirected to express the κ-specific CAR eliminate Igκ+dim tumor cells. T lymphocytes obtained from healthy donors and transduced either with control-GFP vector (A), CAR46ζ (B), or CAR46/28ζ (C) were cocultured with the CCL-120 tumor cell line (ratio, 5:1), which is Igκ+dim. After 5 to 7 days of culture, cells were collected and stained with CD3-PerCP and CD19-PE to evaluate the growth of CD19+ tumor cells. No CD19+ cells were detectable after coculture with CAR46ζ+ or CAR46/28ζ+ T lymphocytes, whereas CD19+ cells were detectable when tumor cells were cocultured with control T cells.

T lymphocytes redirected to express the κ-specific CAR eliminate Igκ+dimtumor cells. T lymphocytes obtained from healthy donors and transduced either with control-GFP vector (A), CAR46ζ (B), or CAR46/28ζ (C) were cocultured with the CCL-120 tumor cell line (ratio, 5:1), which is Igκ+dim. After 5 to 7 days of culture, cells were collected and stained with CD3-PerCP and CD19-PE to evaluate the growth of CD19+ tumor cells. No CD19+ cells were detectable after coculture with CAR46ζ+ or CAR46/28ζ+ T lymphocytes, whereas CD19+ cells were detectable when tumor cells were cocultured with control T cells.

Close Modal

or Create an Account

Close Modal
Close Modal